Marketing of the first biosimilar infliximab in France: what budgetary impact in the public hospitals of Paris?

François Bocquet (1), Isabelle Fusier (2), Anne Laure Cordonnier (2), Philippe Lechat (3), Pascal Paubel (1) (1) General Agency of Equipment and Health Products (AGEPS), Assistance Publique Hôpitaux de Paris (AP-HP), Paris, (France); Health Law and Health Economics Department, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, (France); Health Law Institute, Inserm, UMR […]